๐ฐ Vanitar Aroda News
Vanitar Aroda News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Vanitar Aroda. Real-time updates on events, politics, business and more.
June 27, 2023
Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose
June 26, 2023
/PRNewswire/ -- Late breaking data focused on new drug therapy innovations to treat obesity were presented at the American Diabetes Associationsยฎ (ADA) 83rd...
June 26, 2023
Higher doses of oral semaglutide (25 mg and 50 mg) seem to be effective in type 2 diabetes and obesity, improving upon results obtained with currently approved maximum dose of oral semaglutide 14 mg daily.
June 26, 2023
Data from a pair of trials presented at ADA 2023 suggests an upped dose of oral semaglutide could soon be on the horizon, with results supporting use in chronic weight management as well as type 2 diabetes.
September 26, 2022
No major changes but several shifts in emphasis since the last update in 2019, including weight loss as a co-primary goal of management.
October 28, 2021
With an essential role established for SGLT2 inhibitors for patients with progressive renal dysfunction or heart failure, researchers discuss how best to use these agents in those with type 2 diabetes.